Roblek Marko, Bicher Julia, van Gogh Merel, György Attila, Seeböck Rita, Szulc Bozena, Damme Markus, Olczak Mariusz, Borsig Lubor, Siekhaus Daria E
Institute of Science and Technology Austria, Klosterneuburg, Austria.
Institute of Physiology, University of Zurich, Zurich, Switzerland.
Front Oncol. 2022 Feb 8;12:777634. doi: 10.3389/fonc.2022.777634. eCollection 2022.
Solute carriers are increasingly recognized as participating in a plethora of pathologies, including cancer. We describe here the involvement of the orphan solute carrier Major Facilitator Superfamily Domain-containing protein 1 (MFSD1) in the regulation of tumor cell migration. Loss of MFSD1 enabled higher levels of metastasis in experimental and spontaneous metastasis mouse models. We identified an increased migratory potential in MFSD1 tumor cells which was mediated by increased focal adhesion turnover, reduced stability of mature inactive β1 integrin, and the resulting increased integrin activation index. We show that MFSD1 promoted recycling to the cell surface of endocytosed inactive β1 integrin and thereby protected β1 integrin from proteolytic degradation; this led to dampening of the integrin activation index. Furthermore, downregulation of MFSD1 expression was observed during the early steps of tumorigenesis, and higher MFSD1 expression levels correlate with a better cancer patient prognosis. In sum, we describe a requirement for endolysosomal MFSD1 in efficient β1 integrin recycling to suppress tumor cell dissemination.
溶质载体越来越被认为参与了包括癌症在内的多种病理过程。我们在此描述孤儿溶质载体含主要促进剂超家族结构域蛋白1(MFSD1)在肿瘤细胞迁移调控中的作用。在实验性和自发性转移小鼠模型中,MFSD1的缺失导致更高水平的转移。我们发现MFSD1缺失的肿瘤细胞具有更高的迁移潜能,这是由粘着斑周转增加、成熟无活性β1整合素稳定性降低以及由此导致的整合素激活指数增加介导的。我们表明,MFSD1促进内吞的无活性β1整合素循环至细胞表面,从而保护β1整合素不被蛋白水解降解;这导致整合素激活指数降低。此外,在肿瘤发生的早期阶段观察到MFSD1表达下调,而较高的MFSD1表达水平与癌症患者较好的预后相关。总之,我们描述了内溶酶体MFSD1在有效的β1整合素循环以抑制肿瘤细胞扩散中的必要性。